Vaso Corporation - VASO stock
OTC Symbol: VASO | OTC Tier: OTCQX U.S.
About Vaso Corporation[edit]
Vaso Corporation and its subsidiaries operate in the healthcare equipment and information technology sectors, providing a range of services and products both in the United States and internationally. The company's operations are divided into three segments: IT, Professional Sales Service, and Equipment. The IT segment specializes in healthcare IT and managed network technology services, offering managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed security services. The Professional Sales Service segment focuses on selling healthcare capital equipment for General Electric Healthcare (GEHC) to health providers in the middle market, including GEHC diagnostic imaging capital equipment, service agreements, training, and financial services. The Equipment segment is involved in the design, manufacture, sale, and service of proprietary medical devices, including Biox series Holter monitors and ambulatory blood pressure recorders, ARCS series analysis, reporting, and communication software for ECG and blood pressure, MobiCare multi-parameter wireless vital-sign monitoring systems, and Enhanced External Counterpulsation therapy systems used for non-invasive, outpatient treatment of ischemic heart disease. Vaso Corporation, formerly known as Vasomedical, Inc., changed its name to Vaso Corporation in November 2016 and was incorporated in 1987, with its headquarters located in Plainview, New York.[1]
History[edit]
Vaso Corporation, formerly known as Vasomedical, Inc., was incorporated in 1987. The company was established with a focus on the healthcare equipment and information technology industries. It has its headquarters in Plainview, New York. Over the years, Vaso Corporation has grown and expanded its operations in the healthcare sector, offering a range of services and products to customers in the United States and internationally. The company's three segments, IT, Professional Sales Service, and Equipment, reflect its diverse range of offerings in the healthcare IT and medical equipment sectors. Vaso Corporation's IT segment provides healthcare IT and managed network technology services, while the Professional Sales Service segment focuses on selling healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. The Equipment segment is involved in designing, manufacturing, selling, and servicing proprietary medical devices.[2]
Nasdaq Listing[edit]
Vaso Corporation has revealed its intention to move up from the OTCQX market to the Nasdaq Stock Market through a merger with Achari Ventures Holdings Corp. I ("Achari", NASDAQ: AVHI). Once the transaction is completed, Vaso's common stock and warrants are anticipated to be listed on Nasdaq using the ticker symbol "VASO." Until the proposed business combination is finalized and Nasdaq trading begins, Vaso's common stock will continue to be traded on the OTCQX market under the "VASO" symbol.[3]
- ↑ Yahoo Finance. VASO Stock Profile. Retrieved on 10/5/2023.
- ↑ SEC.gov. Vaso Corporation Description of Business. December 31, 2016.
- ↑ PR Newswire. Vaso Corporation, a Diversified Medical Technology Company Currently Trading on the OTCQX Market, to List on Nasdaq via SPAC Merger. December 7, 2023.
